US drug company Eli Lilly has promised to invest 20% of a $250m biotechnology fund being raised by the Australian state.
US drug company Eli Lilly has promised to invest 20% of a $250m biotechnology fund being raised by the Australian state.
The fund is based in Brisbane, Queensland, and its local government has committed A$25m ($20.9m) to the fund with another tranche of money promised from unnamed US companies.
Lilly is one of the biggest healthcare corporate venturing units through Lilly Ventures and has a strategic investment in Queensland-based biotech firm Protagonist.
Lilly Ventures led a $9m series A round…
